Literature DB >> 33552968

Long Non-Coding RNA-PAICC Promotes the Tumorigenesis of Human Intrahepatic Cholangiocarcinoma by Increasing YAP1 Transcription.

Long Xia1,2,3, Xiaolong Chen1,2, Jiarui Yang2,4, Shuguang Zhu1,2, Lei Zhang2,4, Qi Yin5, Yueyu Hong6, Haoqi Chen1,2, Guihua Chen1,2, Hua Li1,2.   

Abstract

Intrahepatic cholangiocarcinoma (ICC) is a heterogeneous hepatobiliary tumor with poor prognosis, and it lacks reliable prognostic biomarkers and effective therapeutic targets. Long non-coding RNAs (lncRNAs) have been documented to be involved in the progression of various cancers. However, the role of lncRNAs in ICC remains largely unknown. In the present work, we used bioinformatics analysis to identify the differentially expressed lncRNAs in human ICC tissues, among which lncRNA-PAICC was found to be an independent prognostic marker in ICC. Moreover, lncRNA-PAICC promoted the proliferation and invasion of ICC cells. Mechanistically, lncRNA-PAICC acted as a competitive endogenous RNA (ceRNA) that directly sponged the tumor suppressive microRNAs miR-141-3p and miR-27a-3p. The competitive binding property was essential for lncRNA-PAICC to promote tumor growth and metastasis through activating the Hippo pathway. In summary, our results highlighted the important role of the lncRNA-PAICC-miR-141-3p/27a-3p-Yap1 axis in ICC, which offers a novel perspective on the molecular pathogenesis and may serve as a potential target for antimetastatic molecular therapies of ICC.
Copyright © 2021 Xia, Chen, Yang, Zhu, Zhang, Yin, Hong, Chen, Chen and Li.

Entities:  

Keywords:  Hippo pathway; MiR-141-3p; MiR-27a-3p; ceRNA; intrahepatic cholangiocarcinoma; lncRNAs

Year:  2021        PMID: 33552968      PMCID: PMC7856545          DOI: 10.3389/fonc.2020.595533

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  39 in total

Review 1.  The Hippo pathway in normal development and cancer.

Authors:  Marcello Maugeri-Saccà; Ruggero De Maria
Journal:  Pharmacol Ther       Date:  2018-01-03       Impact factor: 12.310

Review 2.  Molecular diagnosis of intrahepatic cholangiocarcinoma.

Authors:  Hiroaki Haga; Tushar Patel
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-09-29       Impact factor: 7.027

Review 3.  Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.

Authors:  Sachin H Patel; Fernando D Camargo; Dean Yimlamai
Journal:  Gastroenterology       Date:  2016-12-19       Impact factor: 22.682

4.  Mutational landscape of intrahepatic cholangiocarcinoma.

Authors:  Shanshan Zou; Jiarui Li; Huabang Zhou; Christian Frech; Xiaolan Jiang; Jeffrey S C Chu; Xinyin Zhao; Yuqiong Li; Qiaomei Li; Hui Wang; Jingyi Hu; Guanyi Kong; Mengchao Wu; Chuanfan Ding; Nansheng Chen; Heping Hu
Journal:  Nat Commun       Date:  2014-12-15       Impact factor: 14.919

Review 5.  Systemic therapies for intrahepatic cholangiocarcinoma.

Authors:  Robin Kate Kelley; John Bridgewater; Gregory J Gores; Andrew X Zhu
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

Review 6.  Long Noncoding RNAs in Cancer Pathways.

Authors:  Adam M Schmitt; Howard Y Chang
Journal:  Cancer Cell       Date:  2016-04-11       Impact factor: 31.743

7.  LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1.

Authors:  Yujia Shan; Jia Ma; Yue Pan; Jialei Hu; Bing Liu; Li Jia
Journal:  Cell Death Dis       Date:  2018-06-18       Impact factor: 8.469

8.  LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis.

Authors:  Xiang-Song Wu; Fang Wang; Huai-Feng Li; Yun-Ping Hu; Lin Jiang; Fei Zhang; Mao-Lan Li; Xu-An Wang; Yun-Peng Jin; Yi-Jian Zhang; Wei Lu; Wen-Guang Wu; Yi-Jun Shu; Hao Weng; Yang Cao; Run-Fa Bao; Hai-Bin Liang; Zheng Wang; Yi-Chi Zhang; Wei Gong; Lei Zheng; Shu-Han Sun; Ying-Bin Liu
Journal:  EMBO Rep       Date:  2017-09-08       Impact factor: 9.071

9.  SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.

Authors:  Yi Xu; Yue Yao; Xingming Jiang; Xiangyu Zhong; Zhidong Wang; Chunlong Li; Pengcheng Kang; Kaiming Leng; Daolin Ji; Zhenglong Li; Lining Huang; Wei Qin; Yunfu Cui
Journal:  J Exp Clin Cancer Res       Date:  2018-04-11

Review 10.  Long Non-Coding RNAs in Biliary Tract Cancer-An Up-to-Date Review.

Authors:  Dino Bekric; Daniel Neureiter; Markus Ritter; Martin Jakab; Martin Gaisberger; Martin Pichler; Tobias Kiesslich; Christian Mayr
Journal:  J Clin Med       Date:  2020-04-22       Impact factor: 4.241

View more
  3 in total

1.  A blood-based noninvasive miRNA signature for predicting survival outcomes in patients with intrahepatic cholangiocarcinoma.

Authors:  Yuma Wada; Mitsuo Shimada; Yuji Morine; Tetsuya Ikemoto; Yu Saito; Hideo Baba; Masaki Mori; Ajay Goel
Journal:  Br J Cancer       Date:  2022-01-25       Impact factor: 9.075

Review 2.  Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma.

Authors:  Yanhua Wu; Khizar Hayat; Yufei Hu; Jianfeng Yang
Journal:  Front Cell Dev Biol       Date:  2022-04-27

Review 3.  Current Advances in Basic and Translational Research of Cholangiocarcinoma.

Authors:  Keisaku Sato; Leonardo Baiocchi; Lindsey Kennedy; Wenjun Zhang; Burcin Ekser; Shannon Glaser; Heather Francis; Gianfranco Alpini
Journal:  Cancers (Basel)       Date:  2021-07-01       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.